All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Courtney Maxey-Jones, MD
Disclosure(s): Abiomed: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Atricure: Consultant (Ongoing), Speaker (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Doctorpedia: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Haemonetics: Advisory Board (Ongoing)

Jeffrey Javidfar, MD

Presentations

1. Introduction and Interactive Baseline Audience Polling
    
2. FDA Device Approval Process: From the Benchtop to the Shelf
   Joseph B. Zwischenberger, MD, FACS
   Disclosure(s): Avalon/Maquet: Royalties (Ongoing); WZ BioTech: Owner/Co-Owner Founder/Co-Founder (Ongoing)
    
3. What Devices Are OK? Discussion of Current MCS Device Recalls
   Leora T. Yarboro, MD
   Disclosure(s): Arthrex: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 22, 2024)
    
4. Informed Consent—How to Discuss Recalls With Patients
   Anna L. Ciullo, MD
    
5. But Will I Be Sued? Medicolegal Aspects of FDA Recalls
   Richard Lee, MD, JD, MBA
   Disclosure(s): Hochman and Lee,LL: Owner/Co-Owner Founder/Co-Founder (Ongoing)
    
6. Panel Discussion & Interactive Audience Survey